Metastatic prostate cancer incidence rose after recommendation against routine screening, and FDA approves first PARP inhibitor for early-stage breast cancer for people with inherited BRCA mutations.

by Eric Fitzsimmons

FDA approves neoadjuvant immunotherapy treatment for lung cancer, and radiation might not be needed for low-risk thyroid cancer.

by Kevin McLaughlin

Study finds lower rates of screening-related breast cancer overdiagnosis and children with cancer in Ukraine continue treatment in hospital’s basement.

by Marci A. Landsmann

Screening program reduces disparities in colorectal cancer, and seeing the challenges of getting cancer care through one woman’s story.

by Eric Fitzsimmons

Aspirin is ineffective in preventing breast cancer recurrence, and immunotherapy holds promise for some patients with advanced anal cancer.

by Kevin McLaughlin

Millions miss cancer screenings, and commercial tobacco ban goes into effect for Navajo Nation after years of failed attempts.

by Marci A. Landsmann

CAR T-cell therapy effects continue 10 years after treatment and first T-cell receptor therapeutic approved for uveal melanoma.

by Eric Fitzsimmons

Pharmacies asked to stop turning immune-compromised people away for fourth shot, and fiber intake is associated with stronger immune response in people with melanoma.

by Marci A. Landsmann

Metastatic cancer patients nearing death continue to receive high-dose radiation despite guidelines advising against it, and new standards are likely to reduce racial disparities in lung cancer screening.

by Kevin McLaughlin

Cancer mortality continues to go down, and a “real-world” study finds more than a third of active surveillance patients are lost to follow-up.

by Eric Fitzsimmons